USPTO 2015–2025 USPTO PatentsView US Corporation

Inscripta Inc.

USPTO PatentsView assignee record - 165 granted patents across 15 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

165
Total patents granted
15
CPC technology areas
19.6
Avg claims per patent
+435%
5-year filing velocity

The verdict

Inscripta holds 165 US patents across 15 technology areas, rank #2,373 of 50,000 tracked assignees.

#2,373
of 50,000 US assignees by volume
Top 22%
by Innovation Score (46.1/100)
19.6
avg claims per patent
+435%
filing velocity, last 5 yrs

Portfolio overview

Inscripta Inc. has been granted 165 US utility patents between 2018 and 2025, placing Inscripta Inc. at rank #2,373 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Inscripta Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Inscripta sits between Amdocs Software Systems Limited (165 patents, rank #2,369) and Amogreentech Co., Ltd. (164 patents, rank #2,377) - the closest US assignees by grant volume. The composite Innovation Score of 46.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 139 grants, compared with 26 in the 2015–2019 window, a +435% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Inscripta Inc.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Inscripta Inc. against peers pursuing similar technology classes.

Who files at Inscripta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Inscripta holds 165 patents at rank #2,373, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Inscripta

By rank, the assignees closest to #2,373 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Inscripta's primary technology class.

Inscripta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0204060 20182019202020212022202320242025 3
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Inscripta Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 3 1.8%
2019 23 13.9%
2020 52 31.5%
2021 35 21.2%
2022 28 17.0%
2023 15 9.1%
2024 6 3.6%
2025 3 1.8%

Which technologies does Inscripta Inc. patent most?

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#2,373

Across all tracked assignees

Innovation Score

46.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Inscripta Inc. hold?
Inscripta Inc. holds 165 US granted patents filed between 2018 and 2025, spanning 15 technology areas.
What is Inscripta Inc.'s Innovation Score?
Inscripta Inc. has an Innovation Score of 46.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Inscripta Inc. focus on?
Inscripta Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 165 patents. The company has filed patents in 15 CPC subclasses total.
Is Inscripta Inc.'s patent filing rate increasing or decreasing?
Inscripta Inc.'s recent filing velocity is +435% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Inscripta Inc.'s patents?
Inscripta Inc.'s patents average 19.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Inscripta Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Inscripta's 165 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Inscripta ranks #2,373 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.